These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31391887)

  • 1. Binding site characterization - similarity, promiscuity, and druggability.
    Ehrt C; Brinkjost T; Koch O
    Medchemcomm; 2019 Jul; 10(7):1145-1159. PubMed ID: 31391887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key.
    Haupt VJ; Daminelli S; Schroeder M
    PLoS One; 2013; 8(6):e65894. PubMed ID: 23805191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
    Salentin S; Haupt VJ; Daminelli S; Schroeder M
    Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
    Chartier M; Morency LP; Zylber MI; Najmanovich RJ
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):18. PubMed ID: 28449705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining global and local measures for structure-based druggability predictions.
    Volkamer A; Kuhn D; Grombacher T; Rippmann F; Rarey M
    J Chem Inf Model; 2012 Feb; 52(2):360-72. PubMed ID: 22148551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Protein Pairs Sharing Common Active Ligands Using Protein Sequence, Structure, and Ligand Similarity.
    Chen YC; Tolbert R; Aronov AM; McGaughey G; Walters WP; Meireles L
    J Chem Inf Model; 2016 Sep; 56(9):1734-45. PubMed ID: 27559831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug promiscuity].
    Guo ZR
    Yao Xue Xue Bao; 2011 Apr; 46(4):361-9. PubMed ID: 21751487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying and characterizing promiscuous targets: implications for virtual screening.
    Pérez-Nueno VI; Ritchie DW
    Expert Opin Drug Discov; 2012 Jan; 7(1):1-17. PubMed ID: 22468890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can We Rely on Computational Predictions To Correctly Identify Ligand Binding Sites on Novel Protein Drug Targets? Assessment of Binding Site Prediction Methods and a Protocol for Validation of Predicted Binding Sites.
    Broomhead NK; Soliman ME
    Cell Biochem Biophys; 2017 Mar; 75(1):15-23. PubMed ID: 27796788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical Profiling of One Promiscuous Protein Binding Site: Illustrated by Urokinase Catalytic Domain.
    Cerisier N; Regad L; Triki D; Petitjean M; Flatters D; Camproux AC
    Mol Inform; 2017 Oct; 36(10):. PubMed ID: 28696518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates to Binding MOAD (Mother of All Databases): Polypharmacology Tools and Their Utility in Drug Repurposing.
    Smith RD; Clark JJ; Ahmed A; Orban ZJ; Dunbar JB; Carlson HA
    J Mol Biol; 2019 Jun; 431(13):2423-2433. PubMed ID: 31125569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Target Druggability Assessment: From Structural to Systemic Approaches.
    Trosset JY; Cavé C
    Methods Mol Biol; 2019; 1953():63-88. PubMed ID: 30912016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational application of drug promiscuity in medicinal chemistry.
    Mei Y; Yang B
    Future Med Chem; 2018 Aug; 10(15):1835-1851. PubMed ID: 30019924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison and druggability prediction of protein-ligand binding sites from pharmacophore-annotated cavity shapes.
    Desaphy J; Azdimousa K; Kellenberger E; Rognan D
    J Chem Inf Model; 2012 Aug; 52(8):2287-99. PubMed ID: 22834646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational drug repurposing to predict approved and novel drug-disease associations.
    Khalid Z; Sezerman OU
    J Mol Graph Model; 2018 Oct; 85():91-96. PubMed ID: 30130693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunsetting Binding MOAD with its last data update and the addition of 3D-ligand polypharmacology tools.
    Wagle S; Smith RD; Dominic AJ; DasGupta D; Tripathi SK; Carlson HA
    Sci Rep; 2023 Feb; 13(1):3008. PubMed ID: 36810894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shape similarity guided pose prediction: lessons from D3R Grand Challenge 3.
    Kumar A; Zhang KYJ
    J Comput Aided Mol Des; 2019 Jan; 33(1):47-59. PubMed ID: 30084081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting drug promiscuity using Gaussian ensemble screening.
    Pérez-Nueno VI; Venkatraman V; Mavridis L; Ritchie DW
    J Chem Inf Model; 2012 Aug; 52(8):1948-61. PubMed ID: 22747187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.